Dec 1, 2022, 01:00 by User Not Found

Clinical Research News | The Summit for Clinical Ops Executives has long been the most impactful destination for in-depth discussions in clinical research. Now the SCOPE community will wield its significant expertise to highlight the new products powering clinical research in the SCOPE Best of Show Awards brought to you by Clinical Research News and ClinEco, the global clinical trials ecosystem and marketplace.

Nov 30, 2022, 09:45 by

Dolomite Bio has announced the launch of the RNAdia 2.0 reagent kit for single cell research. At a significantly lower cost compared to competitor reagents the new and improved RNAdia 2.0 kit alleviates that stress, allowing researchers to focus on what is important, doing more and discovering more.

Nov 30, 2022, 09:44 by

BioPharma Dynamics has announced the expansion of its extensive portfolio to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors, for the Cell & Gene Therapy market.

Nov 30, 2022, 09:35 by

Nov 30, 2022, 09:33 by

Nov 30, 2022, 09:32 by

Genezen appoints Jeff Whitmore as CCO

Nov 30, 2022, 09:32 by

Nov 30, 2022, 01:00 by User Not Found

Clinical Research News | A newly developed immunotherapy drug that delays the onset of type 1 diabetes in at-risk individuals by an average of almost three years; a study to engineer a human heart model, elucidate fundamental laws of muscular pumps, and apply lessons learned to a cardiovascular bio digital twin model; a highly flexible, modular patent-pending platform and wearable sensor designed to meet the specific needs of clinical trials and remote patient research; and more.

Nov 29, 2022, 09:34 by

Nov 29, 2022, 09:34 by

Nov 29, 2022, 09:33 by

Nov 29, 2022, 09:33 by

Nov 29, 2022, 01:00 by User Not Found

Clinical Research News | Funding for clinical-stage urologic oncology pipeline, novel brain cancer research platform, immune microenvironment research of triple-negative breast cancer, and more.

Nov 28, 2022, 15:55 by

Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.

Nov 28, 2022, 15:54 by

Nov 28, 2022, 15:54 by

Nov 28, 2022, 15:53 by

Nov 28, 2022, 15:51 by

Nov 28, 2022, 15:50 by

Nov 28, 2022, 15:50 by